<DOC>
	<DOCNO>NCT00380133</DOCNO>
	<brief_summary>This study assess effect single oral dos SB681323 prednisolone biomarkers induce sputum blood COPD patient</brief_summary>
	<brief_title>Study SB681323 Prednisolone Biomarkers COPD ( Chronic Obstructive Pulmonary Disease ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Inclusion criterion : Subject current smoker exsmoker smoke history least 10 pack year ( number pack year = [ number cigarette per day/20 ] x number year smoke ) . The patient serum CRP â‰¥ 3 mg/L screen Subjects able understand comply protocol requirement , instruction protocolstated restriction . Exclusion criterion : Any clinically relevant abnormality identify medical assessment , laboratory examination , 12lead ECG opinion investigator , lead unacceptable increase risk study participation call question validity outcome measure . Subjects obese , define BMI &gt; 40 Subject diagnosis asthma confirm investigator . Subject poorly control COPD , define occurrence follow 2 week prior visit 1 : acute worsen COPD manage subject home selftreatment corticosteroid antibiotic , require treatment physician . Subject active tuberculosis , lung cancer clinically overt bronchiectasis . Symptoms `` cold flu '' respiratory infection/symptoms start study Subject cardiac , gastrointestinal , neurological , renal , endocrine psychiatric disease uncontrolled permitted medication Subject history allergic rhinitis . Subjects history type malignancy exception successfully treat basal cell cancer skin . Subjects rheumatoid arthritis , connective tissue disorder condition know associate chronic inflammation ( e.g . Inflammatory Bowel Disease ) . Subjects chronic infection gingivitis , periodontitis , prostatitis , gastritis , urinary tract infection . Subjects history hepatic disease . History increase liver function test ( ALT , AST ) upper limit normal past 6 month and/or liver function test ( bilirubin , ALT , AST ) upper limit normal screening . History positive HIV , Hepatitis B /C antibody test result , positive Hep B/C result screen risk factor disease . History drug allergy , , opinion Investigator preclude participation study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>COPD SB-681323 prednisolone biomarkers</keyword>
</DOC>